Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Stocks, par value $0,0001 per share
-
Shares outstanding
-
58.5M
-
Number of holders
-
78
-
Total 13F shares, excl. options
-
22.1M
-
Shares change
-
-2.82M
-
Total reported value, excl. options
-
$30.4M
-
Value change
-
-$9.19M
-
Put/Call ratio
-
0.69
-
Number of buys
-
42
-
Number of sells
-
-60
-
Price
-
$1.37
Significant Holders of BioAtla, Inc. - Common Stocks, par value $0,0001 per share (BCAB) as of Q2 2024
115 filings reported holding BCAB - BioAtla, Inc. - Common Stocks, par value $0,0001 per share as of Q2 2024.
BioAtla, Inc. - Common Stocks, par value $0,0001 per share (BCAB) has 78 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 22.1M shares
of 58.5M outstanding shares and own 37.81% of the company stock.
Largest 10 shareholders include Soleus Capital Management, L.P. (3.9M shares), VANGUARD GROUP INC (1.89M shares), MORGAN STANLEY (1.85M shares), MILLENNIUM MANAGEMENT LLC (1.65M shares), TANG CAPITAL MANAGEMENT LLC (1.37M shares), DEUTSCHE BANK AG\ (1.2M shares), BlackRock Inc. (792K shares), Boxer Capital, LLC (686K shares), AQR CAPITAL MANAGEMENT LLC (636K shares), and Scion Asset Management, LLC (634K shares).
This table shows the top 78 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.